209 related articles for article (PubMed ID: 23248292)
21. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
22. Sir Antagonist 1 (San1) is a ubiquitin ligase.
Dasgupta A; Ramsey KL; Smith JS; Auble DT
J Biol Chem; 2004 Jun; 279(26):26830-8. PubMed ID: 15078868
[TBL] [Abstract][Full Text] [Related]
23. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
[TBL] [Abstract][Full Text] [Related]
24. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
[TBL] [Abstract][Full Text] [Related]
25. Saccharomyces cerevisiae MSH2-MSH3 and MSH2-MSH6 complexes display distinct requirements for DNA binding domain I in mismatch recognition.
Lee SD; Surtees JA; Alani E
J Mol Biol; 2007 Feb; 366(1):53-66. PubMed ID: 17157869
[TBL] [Abstract][Full Text] [Related]
26. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
[TBL] [Abstract][Full Text] [Related]
27. Multiplexed assays reveal effects of missense variants in MSH2 and cancer predisposition.
Nielsen SV; Hartmann-Petersen R; Stein A; Lindorff-Larsen K
PLoS Genet; 2021 Apr; 17(4):e1009496. PubMed ID: 33886538
[No Abstract] [Full Text] [Related]
28. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells.
Diouf B; Cheng Q; Krynetskaia NF; Yang W; Cheok M; Pei D; Fan Y; Cheng C; Krynetskiy EY; Geng H; Chen S; Thierfelder WE; Mullighan CG; Downing JR; Hsieh P; Pui CH; Relling MV; Evans WE
Nat Med; 2011 Sep; 17(10):1298-303. PubMed ID: 21946537
[TBL] [Abstract][Full Text] [Related]
29. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
31. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract][Full Text] [Related]
32. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome.
Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y
Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974
[TBL] [Abstract][Full Text] [Related]
33. Variable Expression of MSH6 in Endometrial Carcinomas With Intact Mismatch Repair and With MLH1 Loss Due to MLH1 Methylation.
Tandon N; Hudgens C; Fellman B; Tetzlaff MT; Broaddus RR
Int J Gynecol Pathol; 2020 Nov; 39(6):507-513. PubMed ID: 31855955
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions.
Martinez SL; Kolodner RD
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5070-5. PubMed ID: 20176959
[TBL] [Abstract][Full Text] [Related]
36. Mutation rates, spectra, and genome-wide distribution of spontaneous mutations in mismatch repair deficient yeast.
Lang GI; Parsons L; Gammie AE
G3 (Bethesda); 2013 Sep; 3(9):1453-65. PubMed ID: 23821616
[TBL] [Abstract][Full Text] [Related]
37. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
Kucherlapati MH; Lee K; Nguyen AA; Clark AB; Hou H; Rosulek A; Li H; Yang K; Fan K; Lipkin M; Bronson RT; Jelicks L; Kunkel TA; Kucherlapati R; Edelmann W
Gastroenterology; 2010 Mar; 138(3):993-1002.e1. PubMed ID: 19931261
[TBL] [Abstract][Full Text] [Related]
38. A rare MSH2 mutation causes defective binding to hMSH6, normal hMSH2 staining, and loss of hMSH6 at advanced cancer stage.
Loconte DC; Patruno M; Lastella P; Di Gregorio C; Grossi V; Forte G; Ingravallo G; Varvara D; Bagnulo R; Simone C; Resta N; Stella A
Hum Pathol; 2014 Oct; 45(10):2162-7. PubMed ID: 25106712
[TBL] [Abstract][Full Text] [Related]
39. Saccharomyces cerevisiae Msh2-Msh6 DNA binding kinetics reveal a mechanism of targeting sites for DNA mismatch repair.
Zhai J; Hingorani MM
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):680-5. PubMed ID: 20080735
[TBL] [Abstract][Full Text] [Related]
40. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
